Abstract
Background Plants constitute promising systems for the alternative production of valuable recombinant proteins. Recently, ELELYSOTM, an enzymatic drug developed by the Israeli company Protalix Biotherapeutics to treat Type 1 Gaucher’s disease, became the first plant-derived therapeutic product to reach marketable status [1]. This confirms the inherent potential of plant systems for the large-scale production of pharmaceuticals and industrial proteins with high quality and at competitive costs. Soybeans [Glycine max (L.) Merrill] provide a potential economically viable platform for the large-scale production of different therapeutic molecules. Plant seeds are specialized in the stable accumulation of proteins at high levels, representing an excellent source of abundant and cheap biomass. Additionally, the vegetative growth of plants can be significantly extended under a daily photoperiod of 23 h of light, inducing more than a tenfold increase in seed production when compared with plants cultivated under field conditions [2]. In this report we present the recombinant biosynthesis and the molecular and functional characterization of two important therapeutic proteins in transgenic soybean seeds: the 22 kDa human growth hormone (hGH) and the 56 kDa human coagulation factor IX (hFIX), a vitamin K-dependent serine-protease glycoprotein utilized to treat Type B Christmas disease, the second most frequent haemophilia variant [3,4].
Highlights
Plants constitute promising systems for the alternative production of valuable recombinant proteins
The transcription levels of the correspondent coding sequences were evaluated by RT-PCR of immature seeds and the accumulation of the proteins in the protein storage vacuoles (PSVs) of the seeds was detected by Western Blot and ultrastructural immunocytochemistry assays
The biological activities of the molecules were evaluated by somatogenic activity bioassay, and by activated partial thromboplastin time assay
Summary
Plants constitute promising systems for the alternative production of valuable recombinant proteins. Methods A biolistic process was used to introduce the plasmids pbcong3hGH (4,786 bp) and pbcong3FIX (5,406 bp), respectively carrying the hgh and hFIX coding sequences under the transcriptional control of the alpha prime (a’) subunit of b-conglycinin tissue-specific promoter from Glycine max (L.) Merrill and the a-Coixin signal peptide from Coix lacryma-jobi, in soybean embryonic axes from mature seeds Independent transgenic lines were analyzed by PCR and characterized by Southern blot.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
